SeaStar Medical Holding Corp has announced that Intracoastal Capital LLC and its associates have acquired a substantial stake in the company. The recent filing indicates that they collectively hold approximately 9.99% of SeaStar's common stock. This development is noteworthy as it may lead to strategic changes within the organization.

Background

SeaStar Medical Holding Corp, classified under SIC 3841, specializes in surgical and medical instruments and apparatus. The company operates on the Nasdaq exchange with the ticker symbols ICU and ICUCW. Recent filings include a 10-Q and an 8-K, both filed on November 12, 2026, providing more insights into the company's financial performance and operational updates.

What the Filing Says

The Schedule 13G/A filing reveals that as of September 30, 2026, Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, beneficially owns 489,105 shares of SeaStar's common stock. This figure represents nearly 9.99% of the total shares outstanding, based on the company's reported figures.

Impact

This ownership stake could potentially affect SeaStar Medical's strategic decisions and governance. The filing indicates that the reporting persons, who are significant stakeholders, may influence the company's direction and operational strategies in the competitive surgical and medical instruments industry.

What's Next

The filing does not say what happens next.